- $13.53bn
- $10.45bn
- $3.12bn
- 93
- 68
- 69
- 91
Annual balance sheet for Genmab A/S, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,639 | 2,957 | 3,214 | 4,166 | 2,930 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 445 | 520 | 848 | 732 | 929 |
| Total Inventory | |||||
| Total Current Assets | 3,084 | 3,476 | 4,062 | 4,906 | 3,867 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 121 | 149 | 190 | 243 | 263 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,470 | 3,765 | 4,336 | 5,225 | 6,361 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 206 | 240 | 262 | 368 | 737 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 332 | 372 | 408 | 545 | 1,265 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 3,139 | 3,394 | 3,927 | 4,680 | 5,095 |
| Total Liabilities & Shareholders' Equity | 3,470 | 3,765 | 4,336 | 5,225 | 6,361 |
| Total Common Shares Outstanding |